Table of Contents Author Guidelines Submit a Manuscript
Journal of Diabetes Research
Volume 2016, Article ID 6809703, 8 pages
http://dx.doi.org/10.1155/2016/6809703
Review Article

The Role of AGE/RAGE Signaling in Diabetes-Mediated Vascular Calcification

1Department of Biological Sciences, Mississippi State University, Mississippi State, MS 39762, USA
2Department of Agricultural and Biological Engineering, Mississippi State University, Mississippi State, MS 39762, USA

Received 8 April 2016; Accepted 19 May 2016

Academic Editor: Konstantinos Papatheodorou

Copyright © 2016 Amber M. Kay et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. National Center for Chronic Disease Prevention and Health Promotion, National Diabetes Statistics Report, 2014, 2014.
  2. D. Mozaffarian, E. J. Benjamin, A. S. Go et al., “Heart disease and stroke statistics—2016 update: a report from the American Heart Association,” Circulation, vol. 133, no. 4, pp. e38–e60, 2016. View at Google Scholar
  3. R. C. Johnson, J. A. Leopold, and J. Loscalzo, “Vascular calcification: pathobiological mechanisms and clinical implications,” Circulation Research, vol. 99, no. 10, pp. 1044–1059, 2006. View at Publisher · View at Google Scholar · View at Scopus
  4. F. Palumbo, C. Bianchi, R. Miccoli, and S. Del Prato, “Hyperglycaemia and cardiovascular risk,” Acta Diabetologica, vol. 40, supplement 2, pp. S362–S369, 2003. View at Publisher · View at Google Scholar · View at Scopus
  5. S. Lehto, L. Niskanen, M. Suhonen, T. Rönnemaa, and M. Laakso, “Medial artery calcification: a neglected harbinger of cardiovascular complications in non-insulin-dependent diabetes mellitus,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 16, no. 8, pp. 978–983, 1996. View at Publisher · View at Google Scholar · View at Scopus
  6. C. M. Giachelli, “Vascular calcification mechanisms,” Journal of the American Society of Nephrology, vol. 15, no. 12, pp. 2959–2964, 2004. View at Publisher · View at Google Scholar · View at Scopus
  7. M. Wu, C. Rementer, and C. M. Giachelli, “Vascular calcification: an update on mechanisms and challenges in treatment,” Calcified Tissue International, vol. 93, no. 4, pp. 365–373, 2013. View at Publisher · View at Google Scholar · View at Scopus
  8. L. L. Demer and Y. Tintut, “Vascular calcification: pathobiology of a multifaceted disease,” Circulation, vol. 117, no. 22, pp. 2938–2948, 2008. View at Publisher · View at Google Scholar · View at Scopus
  9. T. Komori, H. Yagi, S. Nomura et al., “Targeted disruption of Cbfa1 results in a complete lack of bone formation owing to maturational arrest of osteoblasts,” Cell, vol. 89, no. 5, pp. 755–764, 1997. View at Publisher · View at Google Scholar · View at Scopus
  10. K. A. Hruska, S. Mathew, and G. Saab, “Bone morphogenetic proteins in vascular calcification,” Circulation Research, vol. 97, no. 2, pp. 105–114, 2005. View at Publisher · View at Google Scholar · View at Scopus
  11. K.-S. Lee, S.-H. Hong, and S.-C. Bae, “Both the Smad and p38 MAPK pathways play a crucial role in Runx2 expression following induction by transforming growth factor-β and bone morphogenetic protein,” Oncogene, vol. 21, no. 47, pp. 7156–7163, 2002. View at Publisher · View at Google Scholar · View at Scopus
  12. S. A. Steitz, M. Y. Speer, G. Curinga et al., “Smooth muscle cell phenotypic transition associated with calcification: upregulation of Cbfa1 and downregulation of smooth muscle lineage markers,” Circulation Research, vol. 89, no. 12, pp. 1147–1154, 2001. View at Publisher · View at Google Scholar · View at Scopus
  13. M. Weinreb, D. Shinar, and G. A. Rodan, “Different pattern of alkaline phosphatase, osteopontin, and osteocalcin expression in developing rat bone visualized by in situ hybridization,” Journal of Bone and Mineral Research, vol. 5, no. 8, pp. 831–842, 1990. View at Google Scholar · View at Scopus
  14. K. Ibaraki, J. D. Termine, S. W. Whitson, and M. F. Young, “Bone matrix mRNA expression in differentiating fetal bovine osteoblasts,” Journal of Bone and Mineral Research, vol. 7, no. 7, pp. 743–754, 1992. View at Google Scholar · View at Scopus
  15. G. K. Hunter and H. A. Goldberg, “Nucleation of hydroxyapatite by bone sialoprotein,” Proceedings of the National Academy of Sciences of the United States of America, vol. 90, no. 18, pp. 8562–8565, 1993. View at Publisher · View at Google Scholar · View at Scopus
  16. H. Orimo, “The mechanism of mineralization and the role of alkaline phosphatase in health and disease,” Journal of Nippon Medical School, vol. 77, no. 1, pp. 4–12, 2010. View at Publisher · View at Google Scholar · View at Scopus
  17. B. Ganss, R. H. Kim, and J. Sodek, “Bone sialoprotein,” Critical Reviews in Oral Biology and Medicine, vol. 10, no. 1, pp. 79–98, 1999. View at Publisher · View at Google Scholar · View at Scopus
  18. Y. Yang, Q. Cui, and N. Sahai, “How does bone sialoprotein promote the nucleation of hydroxyapatite? A molecular dynamics study using model peptides of different conformations,” Langmuir, vol. 26, no. 12, pp. 9848–9859, 2010. View at Publisher · View at Google Scholar · View at Scopus
  19. J. Sodek, B. Ganss, and M. D. McKee, “Osteopontin,” Critical Reviews in Oral Biology and Medicine, vol. 11, no. 3, pp. 279–303, 2000. View at Publisher · View at Google Scholar · View at Scopus
  20. S. L. Booth, A. Centi, S. R. Smith, and C. Gundberg, “The role of osteocalcin in human glucose metabolism: marker or mediator?” Nature Reviews Endocrinology, vol. 9, no. 1, pp. 43–55, 2013. View at Publisher · View at Google Scholar · View at Scopus
  21. N. X. Chen, D. Duan, K. D. O'Neill, and S. M. Moe, “High glucose increases the expression of Cbfa1 and BMP-2 and enhances the calcification of vascular smooth muscle cells,” Nephrology Dialysis Transplantation, vol. 21, no. 12, pp. 3435–3442, 2006. View at Publisher · View at Google Scholar · View at Scopus
  22. D. Koya and G. L. King, “Protein kinase C activation and the development of diabetic complications,” Diabetes, vol. 47, no. 6, pp. 859–866, 1998. View at Publisher · View at Google Scholar · View at Scopus
  23. A. K. Srivastava, “High glucose-induced activation of protein kinase signaling pathways in vascular smooth muscle cells: a potential role in the pathogenesis of vascular dysfunction in diabetes (review),” International Journal of Molecular Medicine, vol. 9, no. 1, pp. 85–89, 2002. View at Google Scholar · View at Scopus
  24. N. X. Chen, D. Duan, K. D. O'Neill et al., “The mechanisms of uremic serum-induced expression of bone matrix proteins in bovine vascular smooth muscle cells,” Kidney International, vol. 70, no. 6, pp. 1046–1053, 2006. View at Publisher · View at Google Scholar · View at Scopus
  25. S. Mori, M. Takemoto, K. Yokote, S. Asaumi, and Y. Saito, “Hyperglycemia-induced alteration of vascular smooth muscle phenotype,” Journal of Diabetes and Its Complications, vol. 16, no. 1, pp. 65–68, 2002. View at Publisher · View at Google Scholar · View at Scopus
  26. M. Takemoto, K. Yokote, M. Nishimura et al., “Enhanced expression of osteopontin in human diabetic artery and analysis of its functional role in accelerated atherogenesis,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 20, no. 3, pp. 624–628, 2000. View at Google Scholar · View at Scopus
  27. M. Takemoto, K. Yokote, M. Yamazaki et al., “Enhanced expression of osteopontin by high glucose in cultured rat aortic smooth muscle cells,” Biochemical and Biophysical Research Communications, vol. 258, no. 3, pp. 722–726, 1999. View at Publisher · View at Google Scholar · View at Scopus
  28. S. Soman, R. Raju, V. K. Sandhya et al., “A multicellular signal transduction network of AGE/RAGE signaling,” Journal of Cell Communication and Signaling, vol. 7, no. 1, pp. 19–23, 2013. View at Publisher · View at Google Scholar · View at Scopus
  29. A. W. Stitt, Y. M. Li, T. A. Gardiner, R. Bucala, D. B. Archer, and H. Vlassara, “Advanced glycation end products (AGEs) co-localize with AGE receptors in the retinal vasculature of diabetic and of AGE-infused rats,” American Journal of Pathology, vol. 150, no. 2, pp. 523–531, 1997. View at Google Scholar · View at Scopus
  30. A. W. Stitt, J. E. Moore, J. A. Sharkey et al., “Advanced glycation end products in vitreous: structural and functional implications for diabetic vitreopathy,” Investigative Ophthalmology & Visual Science, vol. 39, no. 13, pp. 2517–2523, 1998. View at Google Scholar · View at Scopus
  31. F. Giacco and M. Brownlee, “Oxidative stress and diabetic complications,” Circulation Research, vol. 107, no. 9, pp. 1058–1070, 2010. View at Publisher · View at Google Scholar · View at Scopus
  32. R. Singh, A. Barden, T. Mori, and L. Beilin, “Advanced glycation end-products: a review,” Diabetologia, vol. 44, no. 2, pp. 129–146, 2001. View at Publisher · View at Google Scholar · View at Scopus
  33. A. Goldin, J. A. Beckman, A. M. Schmidt, and M. A. Creager, “Advanced glycation end products: sparking the development of diabetic vascular injury,” Circulation, vol. 114, no. 6, pp. 597–605, 2006. View at Publisher · View at Google Scholar · View at Scopus
  34. M. Sakaguchi, H. Murata, K.-I. Yamamoto et al., “TIRAP, an adaptor protein for TLR2/4, transduces a signal from RAGE phosphorylated upon ligand binding,” PLoS ONE, vol. 6, no. 8, article e23132, 2011. View at Publisher · View at Google Scholar · View at Scopus
  35. P. Geraldes and G. L. King, “Activation of protein kinase C isoforms and its impact on diabetic complications,” Circulation Research, vol. 106, no. 8, pp. 1319–1331, 2010. View at Publisher · View at Google Scholar · View at Scopus
  36. T. Suga, T. Iso, T. Shimizu et al., “Activation of receptor for advanced glycation end products induces osteogenic differentiation of vascular smooth muscle cells,” Journal of Atherosclerosis and Thrombosis, vol. 18, no. 8, pp. 670–683, 2011. View at Publisher · View at Google Scholar · View at Scopus
  37. T. Tanikawa, Y. Okada, R. Tanikawa, and Y. Tanaka, “Advanced glycation end products induce calcification of vascular smooth muscle cells through rage/p38 MAPK,” Journal of Vascular Research, vol. 46, no. 6, pp. 572–580, 2009. View at Publisher · View at Google Scholar · View at Scopus
  38. Y. Hu, E. Chan, S. X. Wang, and B. Li, “Activation of p38 mitogen-activated protein kinase is required for osteoblast differentiation,” Endocrinology, vol. 144, no. 5, pp. 2068–2074, 2003. View at Publisher · View at Google Scholar · View at Scopus
  39. X. Ren, H. Shao, Q. Wei, Z. Sun, and N. Liu, “Advanced glycation end-products enhance calcification in vascular smooth muscle cells,” Journal of International Medical Research, vol. 37, no. 3, pp. 847–854, 2009. View at Publisher · View at Google Scholar · View at Scopus
  40. S. M. Moe, D. Duan, B. P. Doehle, K. D. O'Neill, and N. X. Chen, “Uremia induces the osteoblast differentiation factor Cbfa1 in human blood vessels,” Kidney International, vol. 63, no. 3, pp. 1003–1011, 2003. View at Publisher · View at Google Scholar · View at Scopus
  41. Q. Wei, X. Ren, Y. Jiang, H. Jin, N. Liu, and J. Li, “Advanced glycation end products accelerate rat vascular calcification through RAGE/oxidative stress,” BMC Cardiovascular Disorders, vol. 13, article 13, 2013. View at Publisher · View at Google Scholar · View at Scopus
  42. N. Stefan, A. Fritsche, C. Weikert et al., “Plasma fetuin-A levels and the risk of type 2 diabetes,” Diabetes, vol. 57, no. 10, pp. 2762–2767, 2008. View at Publisher · View at Google Scholar · View at Scopus
  43. M. Singh, P. K. Sharma, V. K. Garg, S. C. Mondal, A. K. Singh, and N. Kumar, “Role of fetuin-A in atherosclerosis associated with diabetic patients,” Journal of Pharmacy and Pharmacology, vol. 64, no. 12, pp. 1703–1708, 2012. View at Publisher · View at Google Scholar · View at Scopus
  44. A. Song, M. Xu, Y. Bi et al., “Serum fetuin-A associates with type 2 diabetes and insulin resistance in Chinese adults,” PLoS ONE, vol. 6, no. 4, Article ID e19228, 2011. View at Publisher · View at Google Scholar · View at Scopus
  45. N. J. Paloian and C. M. Giachelli, “A current understanding of vascular calcification in CKD,” American Journal of Physiology—Renal Physiology, vol. 307, no. 8, pp. F891–F900, 2014. View at Publisher · View at Google Scholar · View at Scopus
  46. I. Hameed, S. R. Masoodi, S. A. Mir, M. Nabi, K. Ghazanfar, and B. A. Ganai, “Type 2 diabetes mellitus: from a metabolic disorder to an inflammatory condition,” World Journal of Diabetes, vol. 6, no. 4, pp. 598–612, 2015. View at Google Scholar
  47. D. Pal, S. Dasgupta, R. Kundu et al., “Fetuin-A acts as an endogenous ligand of TLR4 to promote lipid-induced insulin resistance,” Nature Medicine, vol. 18, no. 8, pp. 1279–1285, 2012. View at Publisher · View at Google Scholar · View at Scopus
  48. H. Wang and A. E. Sama, “Anti-inflammatory role of fetuin-A in injury and infection,” Current Molecular Medicine, vol. 12, no. 5, pp. 625–633, 2012. View at Publisher · View at Google Scholar · View at Scopus
  49. R. Kokkola, Å. Andersson, G. Mullins et al., “RAGE is the major receptor for the proinflammatory activity of HMGB1 in rodent macrophages,” Scandinavian Journal of Immunology, vol. 61, no. 1, pp. 1–9, 2005. View at Publisher · View at Google Scholar · View at Scopus
  50. T. Schinke, C. Amendt, A. Trindl, O. Pöschke, W. Müller-Esterl, and W. Jahnen-Dechent, “The serum protein α2-HS glycoprotein/fetuin inhibits apatite formation in vitro and in mineralizing calvaria cells. A possible role in mineralization and calcium homeostasis,” The Journal of Biological Chemistry, vol. 271, no. 34, pp. 20789–20796, 1996. View at Publisher · View at Google Scholar · View at Scopus
  51. K. Janda, M. Krzanowski, M. Gajda et al., “Vascular effects of advanced glycation end-products: content of immunohistochemically detected AGEs in radial artery samples as a predictor for arterial calcification and cardiovascular risk in asymptomatic patients with chronic kidney disease,” Disease Markers, vol. 2015, Article ID 153978, 9 pages, 2015. View at Publisher · View at Google Scholar · View at Scopus
  52. M. Ketteler, P. Bongartz, R. Westenfeld et al., “Association of low fetuin-A (AHSG) concentrations in serum with cardiovascular mortality in patients on dialysis: a cross-sectional study,” The Lancet, vol. 361, no. 9360, pp. 827–833, 2003. View at Publisher · View at Google Scholar · View at Scopus
  53. A. M. El-Shehaby, A. Zakaria, M. El-Khatib, and N. Mostafa, “Association of fetuin-A and cardiac calcification and inflammation levels in hemodialysis patients,” Scandinavian Journal of Clinical and Laboratory Investigation, vol. 70, no. 8, pp. 575–582, 2010. View at Publisher · View at Google Scholar · View at Scopus
  54. C. Schäfer, A. Heiss, A. Schwarz et al., “The serum protein α2-Heremans-Schmid glycoprotein/fetuin-A is a systemically acting inhibitor of ectopic calcification,” The Journal of Clinical Investigation, vol. 112, no. 3, pp. 357–366, 2003. View at Publisher · View at Google Scholar · View at Scopus
  55. A. Heiss, A. DuChesne, B. Denecke et al., “Structural basis of calcification inhibition by α2-HS glycoprotein/fetuin-A: formation of colloidal calciprotein particles,” Journal of Biological Chemistry, vol. 278, no. 15, pp. 13333–13341, 2003. View at Publisher · View at Google Scholar · View at Scopus
  56. E. S. Vasquez, J. L. Cunningham, J. B. McMahan, C. L. Simpson, and K. B. Walters, “Fetuin-A adsorption and stabilization of calcium carbonate nanoparticles in a simulated body fluid,” Journal of Materials Chemistry B, vol. 3, no. 31, pp. 6411–6419, 2015. View at Publisher · View at Google Scholar · View at Scopus
  57. J. L. Reynolds, J. N. Skepper, R. McNair et al., “Multifunctional roles for serum protein fetuin-A in inhibition of human vascular smooth muscle cell calcification,” Journal of the American Society of Nephrology, vol. 16, no. 10, pp. 2920–2930, 2005. View at Publisher · View at Google Scholar · View at Scopus
  58. J. L. Reynolds, A. J. Joannides, J. N. Skepper et al., “Human vascular smooth muscle cells undergo vesicle-mediated calcification in response to changes in extracellular calcium and phosphate concentrations: a potential mechanism for accelerated vascular calcification in ESRD,” Journal of the American Society of Nephrology, vol. 15, no. 11, pp. 2857–2867, 2004. View at Publisher · View at Google Scholar · View at Scopus
  59. D. Proudfoot, J. N. Skepper, L. Hegyi, M. R. Bennett, C. M. Shanahan, and P. L. Weissberg, “Apoptosis regulates human vascular calcification in vitro: evidence for initiation of vascular calcification by apoptotic bodies,” Circulation Research, vol. 87, no. 11, pp. 1055–1062, 2000. View at Publisher · View at Google Scholar · View at Scopus
  60. M. El-Abbadi and C. M. Giachelli, “Mechanisms of vascular calcification,” Advances in Chronic Kidney Disease, vol. 14, no. 1, pp. 54–66, 2007. View at Publisher · View at Google Scholar · View at Scopus
  61. S. M. Moe, M. Reslerova, M. Ketteler et al., “Role of calcification inhibitors in the pathogenesis of vascular calcification in chronic kidney disease (CKD),” Kidney International, vol. 67, no. 6, pp. 2295–2304, 2005. View at Publisher · View at Google Scholar · View at Scopus
  62. G. Daffu, C. H. del Pozo, K. M. O'Shea, R. Ananthakrishnan, R. Ramasamy, and A. M. Schmidt, “Radical roles for RAGE in the pathogenesis of oxidative stress in cardiovascular diseases and beyond,” International Journal of Molecular Sciences, vol. 14, no. 10, pp. 19891–19910, 2013. View at Publisher · View at Google Scholar · View at Scopus
  63. K. R. Hutchinson, C. K. Lord, T. A. West, and J. A. Stewart Jr., “Cardiac fibroblast-dependent extracellular matrix accumulation is associated with diastolic stiffness in type 2 diabetes,” PLoS ONE, vol. 8, no. 8, Article ID e72080, 2013. View at Publisher · View at Google Scholar · View at Scopus
  64. J. L. Rains and S. K. Jain, “Oxidative stress, insulin signaling, and diabetes,” Free Radical Biology and Medicine, vol. 50, no. 5, pp. 567–575, 2011. View at Publisher · View at Google Scholar · View at Scopus
  65. M. R. Brodeur, C. Bouvet, S. Bouchard et al., “Reduction of advanced-glycation end products levels and inhibition of RAGE signaling decreases rat vascular calcification induced by diabetes,” PLoS ONE, vol. 9, no. 1, Article ID e85922, 2014. View at Publisher · View at Google Scholar
  66. J. H. Li, X. R. Huang, H.-J. Zhu et al., “Advanced glycation end products activate Smad signaling via TGF-beta-dependent and independent mechanisms: implications for diabetic renal and vascular disease,” The FASEB Journal, vol. 18, no. 1, pp. 176–178, 2004. View at Google Scholar · View at Scopus
  67. C. M. Zimmerman and R. W. Padgett, “Transforming growth factor β signaling mediators and modulators,” Gene, vol. 249, no. 1-2, pp. 17–30, 2000. View at Publisher · View at Google Scholar · View at Scopus
  68. R.-M. Liu and K. A. Gaston Pravia, “Oxidative stress and glutathione in TGF-β-mediated fibrogenesis,” Free Radical Biology and Medicine, vol. 48, no. 1, pp. 1–15, 2010. View at Publisher · View at Google Scholar · View at Scopus
  69. E. Simard, T. Söllradl, J.-S. Maltais, J. Boucher, P. D'Orléans-Juste, and M. Grandbois, “Receptor for advanced glycation end-products signaling interferes with the vascular smooth muscle cell contractile phenotype and function,” PLoS ONE, vol. 10, no. 8, Article ID e0128881, 2015. View at Publisher · View at Google Scholar · View at Scopus
  70. Y. Peng, J.-M. Kim, H.-S. Park et al., “AGE-RAGE signal generates a specific NF-κB RelA ‘barcode’ that directs collagen I expression,” Scientific Reports, vol. 6, Article ID 18822, 2016. View at Publisher · View at Google Scholar · View at Scopus